Cancer epigenetics reaches mainstream oncology

M Rodríguez-Paredes, M Esteller - Nature medicine, 2011 - nature.com
Epigenetics is one of the most promising and expanding fields in the current biomedical
research landscape. Since the inception of epigenetics in the 1940s, the discoveries …

Cancer epigenetics

R Taby, JPJ Issa - CA: a cancer journal for clinicians, 2010 - Wiley Online Library
Epigenetics refers to stable alterations in gene expression with no underlying modifications
in the genetic sequence and is best exemplified by differentiation, in which multiple cell …

[HTML][HTML] Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives

J Ibrahim, M Peeters, G Van Camp… - European Journal of …, 2023 - Elsevier
The increase in recent scientific studies on cancer biomarkers has brought great new
insights into the field. Moreover, novel technological breakthroughs such as long read …

Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies

C Palanca-Ballester, A Rodriguez-Casanova, S Torres… - Cancers, 2021 - mdpi.com
Simple Summary Apart from genetic changes, cancer is characterized by epigenetic
alterations, which indicate modifications in the DNA (such as DNA methylation) and histones …

Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma

MR Morris, CJ Ricketts, D Gentle, F McRonald, N Carli… - Oncogene, 2011 - nature.com
The detection of promoter region hypermethylation and transcriptional silencing has
facilitated the identification of candidate renal cell carcinoma (RCC) tumour suppressor …

DNA methylation-based biomarkers in bladder cancer

R Kandimalla, AA Van Tilborg, EC Zwarthoff - Nature Reviews Urology, 2013 - nature.com
Urinary bladder cancer is the fifth most common cancer in the Western world. Increasing
evidence has shown that DNA methylation in bladder cancer is expansive and is implicated …

Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor …

T Reinert, C Modin, FM Castano, P Lamy… - Clinical cancer …, 2011 - AACR
Purpose: Epigenetic alterations are common and can now be addressed in a parallel
fashion. We investigated the methylation in bladder cancer with respect to location in …

Urine markers for detection and surveillance of non–muscle-invasive bladder cancer

D Tilki, M Burger, G Dalbagni, HB Grossman… - European urology, 2011 - Elsevier
CONTEXT: Bladder cancer diagnosis and surveillance includes cystoscopy and cytology.
The limitation of urinary cytology is its low sensitivity for low-grade recurrences. As of now …

Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer

R Guerrero-Preston, C Michailidi, L Marchionni… - Epigenetics, 2014 - Taylor & Francis
Tumor suppressor genes (TSGs) are commonly inactivated by somatic mutation and/or
promoter methylation; yet, recent high-throughput genomic studies have not identified key …

GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer

DMEI Hellebrekers, MHFM Lentjes… - Clinical cancer …, 2009 - AACR
Purpose: The transcription factors GATA4 and GATA5 are involved in gastrointestinal
development and are inactivated by promoter hypermethylation in colorectal cancer. Here …